Delivery Order SPE2DB22D3501-SPE2DB25FUP85

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Erythromycin 250 mg tablets to support government healthcare programs. The $5,148.79 delivery order contract has a firm fixed price and a completion date of October 11, 2024. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports defense and healthcare requirements. Amerisourcebergen holds several Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $25,199.43 firm fixed-price delivery order is for the supply of 4,565,511,300 units of 250mg Erythromycin tablets. The contract has an ultimate completion date of August 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,556.05 firm fixed-price Delivery Order, awarded on February 1, 2024, is for the supply of 4,563,518,988 units of Erythromycin 250 mg tablets to support military healthcare programs. The contract has an ultimate completion date of February 2, 2024 and is not designated with a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,391.82 firm fixed-price delivery order is for the supply of Erythromycin 500 mg tablets to support military treatment facilities and federal healthcare programs. The award is a delivery order under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,124.46 firm fixed-price delivery order is for the supply of 4,567,015,776 units of the drug Erythromycin 250 mg tablets. The contract has an ultimate completion date of January 24, 2025 and was awarded on January 23, 2025. The award is not associated with a set-aside program. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,573.38 firm fixed-price delivery order is for the supply of 4,567,130,712 units of Erythromycin 250 mg tablets. The contract has a period of performance through February 4, 2025 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $6,421.63, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,565,289,298 units of Erythromycin 250 mg tablets, a critical pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025 for a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,276.41, is for the delivery of 4560660358 - Erythromycin 250 mg Tablet 30s. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 21, 2023. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at up to $1,059.34, is a firm fixed price delivery order for the supply of 4,565,014,823 Erythromycin 250 mg tablets. This award is a task order under an existing Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, which has a...
This federal contract award, valued at $5,984.67, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The award is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUP85
    Delivery Order

This federal contract award, valued at $2,970.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4567303550 - Erythromycin 250 mg Tablets, 30s, with a completion date of February 19, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is part of that larger IDC contract. No set-aside designation was used for this award.

Generated 5/20/25, 2:00 PM